High-Glucose Environment Enhanced Oxidative Stress and Increased Interleukin-8 Secretion From Keratinocytes

Impaired wound healing frequently occurs in patients with diabetes. Interleukin (IL)-8 production by keratinocyte is responsible for recruiting neutrophils during healing. Intense inflammation is associated with diabetic wounds, while reduction of neutrophil infiltration is associated with enhanced healing. We hypothesized that increased neutrophil recruitment by keratinocytes may contribute to the delayed healing of diabetic wounds. Using cultured human keratinocytes and a diabetic rat model, the current study shows that a high-glucose environment enhanced IL-8 production via epidermal growth factor receptor (EGFR)–extracellular signal–regulated kinase (ERK) pathway in a reactive oxygen species (ROS)-dependent manner in keratinocytes. In addition, diabetic rat skin showed enhanced EGFR, ERK, and IL-8 expression compared with control rats. The dermal neutrophil infiltration of the wound, as represented by expression of myeloperoxidase level, was also significantly higher in diabetic rats. Treating diabetic rats with dapsone, an agent known to inhibit neutrophil function, was associated with improved healing. In conclusion, IL-8 production and neutrophil infiltration are increased in a high-glucose environment due to elevated ROS level and contributed to impaired wound healing in diabetic skin. Targeting these dysfunctions may present novel therapeutic approaches.

[1]  S. Kunkel,et al.  Neutrophil-derived cytokines: potential therapeutic targets in inflammation. , 2005, Current drug targets. Inflammation and allergy.

[2]  A. Schmidtchen,et al.  Injury is a major inducer of epidermal innate immune responses during wound healing. , 2010, The Journal of investigative dermatology.

[3]  D. Greenhalgh,et al.  Cutaneous Wound Healing , 2007, Journal of burn care & research : official publication of the American Burn Association.

[4]  Meiling Jin,et al.  Potential mechanism of interleukin‐8 production from lung cancer cells: An involvement of EGF–EGFR–PI3K–Akt–Erk pathway , 2012, Journal of cellular physiology.

[5]  M. Baggiolini,et al.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.

[6]  H. Gerlach,et al.  Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas , 1988, Journal of Experimental Medicine.

[7]  Chidchamai Kewcharoenwong,et al.  Human Polymorphonuclear Neutrophil Responses to Burkholderia pseudomallei in Healthy and Diabetic Subjects , 2008, Infection and Immunity.

[8]  L. Ellis,et al.  Interleukin-1β stimulates IL-8 expression through MAP kinase and ROS signaling in human gastric carcinoma cells , 2004, Oncogene.

[9]  D. Connolly,et al.  Vascular permeability factor, an endothelial cell mitogen related to PDGF. , 1989, Science.

[10]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[11]  Y. Lim,et al.  Short term supplementation of dietary antioxidants selectively regulates the inflammatory responses during early cutaneous wound healing in diabetic mice , 2011, Nutrition & metabolism.

[12]  Paul Martin,et al.  Inflammatory cells during wound repair: the good, the bad and the ugly. , 2005, Trends in cell biology.

[13]  L. Ellis,et al.  Interleukin-1beta stimulates IL-8 expression through MAP kinase and ROS signaling in human gastric carcinoma cells. , 2004, Oncogene.

[14]  M. Ezzati,et al.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants , 2011, The Lancet.

[15]  W. Goodson,et al.  Studies of wound healing in experimental diabetes mellitus. , 1977, The Journal of surgical research.

[16]  C. Chai,et al.  High-Glucose Environment Inhibits p38MAPK Signaling and Reduces Human β-3 Expression in Keratinocytes , 2011, Molecular medicine.

[17]  J. Pfeilschifter,et al.  The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Attenuates Inflammation and Accelerates Epithelialization in Wounds of Diabetic ob/ob Mice , 2012, Journal of Pharmacology and Experimental Therapeutics.

[18]  T. Krieg,et al.  Inflammation in wound repair: molecular and cellular mechanisms. , 2007, The Journal of investigative dermatology.

[19]  D. McCance,et al.  Down Regulation of the Interleukin-8 Promoter by Human Papillomavirus Type 16 E6 and E7 through Effects on CREB Binding Protein/p300 and P/CAF , 2002, Journal of Virology.

[20]  K. Moore.  Cell biology of chronic wounds: the role of inflammation. , 1999, Journal of wound care.

[21]  L. Klotz,et al.  Extracellular generation of hydrogen peroxide is responsible for activation of EGF receptor by ultraviolet A radiation. , 2006, Free radical biology & medicine.

[22]  K. Schroeder,et al.  Studies of cell signaling in a reconstructed human epidermis exposed to sensitizers: IL-8 synthesis and release depend on EGFR activation , 2012, Archives of Dermatological Research.

[23]  B. Lehmann,et al.  Dapsone inhibits the generation of 5-lipoxygenase products in human polymorphonuclear leukocytes. , 1995, Skin pharmacology : the official journal of the Skin Pharmacology Society.

[24]  Zhijie Li,et al.  Advanced glycation end products and lipopolysaccharide synergistically stimulate proinflammatory cytokine/chemokine production in endothelial cells via activation of both mitogen‐activated protein kinases and nuclear factor‐κB , 2009, The FEBS journal.

[25]  K. Yoneda,et al.  Angiotensin II enhances EGF receptor expression levels via ROS formation in HaCaT cells. , 2008, Journal of dermatological science.

[26]  R. Ross,et al.  The neutrophilic leukocyte in wound repair a study with antineutrophil serum. , 1972, The Journal of clinical investigation.

[27]  Shu-zheng Liu,et al.  UVB induced oxidative stress in human keratinocytes and protective effect of antioxidant agents , 2007, Radiation and environmental biophysics.

[28]  D. Accili,et al.  The regulation of skin proliferation and differentiation in the IR null mouse: implications for skin complications of diabetes. , 2001, Endocrinology.

[29]  L. DiPietro,et al.  Accelerated wound closure in neutrophil‐depleted mice , 2003, Journal of leukocyte biology.

[30]  Vincent Falanga,et al.  Wound healing and its impairment in the diabetic foot , 2005, The Lancet.

[31]  G. Laurent,et al.  Mechanisms of tissue repair: from wound healing to fibrosis. , 1997, The international journal of biochemistry & cell biology.

[32]  L. Téot,et al.  Fibronectin potentiates topical erythropoietin-induced wound repair in diabetic mice. , 2011, The Journal of investigative dermatology.

[33]  C‐S. Wu,et al.  Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes , 2008, The British journal of dermatology.

[34]  B. Dewald,et al.  A novel neutrophil-activating factor produced by human mononuclear phagocytes , 1988, The Journal of experimental medicine.

[35]  M. Sticherling,et al.  Bioactive interleukin-8 is expressed in wounds and enhances wound healing. , 2000, The Journal of surgical research.

[36]  G. Pierce.  Inflammation in nonhealing diabetic wounds: the space-time continuum does matter. , 2001, The American journal of pathology.